Romain Noel
9Patents
1h-index
10Co-inventors
40Inventor score
Filing activity: Oct 18, 2013 → Aug 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11633460B2 | Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals | Chemistry; Metallurgy | 1 | Active |
| US9540356B2 | Compounds having a protective activity against toxins with intracellular activity | Chemistry; Metallurgy | 1 | Active |
| US11191812B2 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid | Human Necessities | 1 | Active |
| US10987426B2 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid | Chemistry; Metallurgy | 0 | Active |
| US12186373B2 | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid | Chemistry; Metallurgy | 0 | Active |
| US11129877B2 | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid | Chemistry; Metallurgy | 0 | Active |
| US11883496B2 | Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals | Chemistry; Metallurgy | 0 | Active |
| US11173109B2 | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | Human Necessities | 0 | Active |
| US9675615B2 | 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.